Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy

Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy

Abstract Background Breast cancer is one of the most lethal cancers in women. Despite significant advances in the diagnosis and treatment of breast cancer, many patients still succumb to this disease, and thus, novel effective treatments are urgently needed. Natural product coumarin has been broadly...

書目詳細資料
Main Authors:	Sujie Zhu, Wenjing Zhu, Kaihua Zhao, Jie Yu, Wenxia Lu, Rui Zhou, Shule Fan, Weikaixin Kong, Feifei Yang, Peipei Shan
格式:	Article
語言:	English
出版:	BMC 2024-07-01
叢編:	Cell Communication and Signaling
主題:	Breast cancer Metastasis Tumor growth Histone deacetylases inhibitor Coumarins FOSL2
在線閱讀:	https://doi.org/10.1186/s12964-024-01733-4

相似書籍

The Role of HDACs as Leukemia Therapy Targets using HDI
由: Ahmad Ahmadzadeh, et al.
出版: (2016-02-01)

KLF14 inhibits tumor progression via FOSL1 in glioma
由: Xiaohua Wang, et al.
出版: (2025-03-01)

Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities
由: Feifei Yang, et al.
出版: (2019-07-01)

Influence of FOSL1 Inhibition on Vascular Calcification and ROS Generation through Ferroptosis via P53-SLC7A11 Axis
由: Sisi Shao, et al.
出版: (2023-02-01)

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
由: Donglu Wu, et al.
出版: (2020-11-01)

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
由: Carolina Marques, et al.
出版: (2021-08-01)

All for one and FOSL1 for all: FOSL1 at the crossroads of lung and pancreatic cancer driven by mutant KRAS
由: Adrian Vallejo, et al.
出版: (2017-05-01)

FOSL1 promotes tumor growth and invasion in ameloblastoma
由: Gan Xiong, et al.
出版: (2022-09-01)

Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
由: Wanli Zhang, et al.
出版: (2025-02-01)

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
由: Anton Frühauf, et al.
出版: (2021-08-01)

PMAIP1 regulates the progression of follicular thyroid carcinoma through the Wnt3/FOSL1 pathway
由: Haobo Wang, et al.
出版: (2025-01-01)

HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
由: Jie Wang, et al.
出版: (2022-12-01)

Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway
由: Mingyue Tan, et al.
出版: (2023-11-01)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
由: Saikat Dewanjee, et al.
出版: (2021-05-01)

The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
由: Edoardo Cellupica, et al.
出版: (2023-07-01)

FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer
由: Qingling He, et al.
出版: (2024-11-01)

FOSL2 activates TGF‐β1‐mediated GLUT1/mTOR signaling to promote diabetic kidney disease
由: Xuelin He, et al.
出版: (2025-02-01)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
由: Jacob King, et al.
出版: (2021-11-01)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
由: Elizabeth A. Thomas
出版: (2014-05-01)

HDAC1-mediated deacetylation of HIF1α prevents atherosclerosis progression by promoting miR-224-3p-mediated inhibition of FOSL2
由: Hao Wang, et al.
出版: (2021-03-01)

FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system
由: Xiaolong Liu, et al.
出版: (2025-03-01)

MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma
由: Wei Wang, et al.
出版: (2022-08-01)

Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies
由: Santiago García, et al.
出版: (2020-11-01)

Current HDAC Inhibitors in Clinical Trials
由: Elisabetta Di Bello, et al.
出版: (2022-05-01)

Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
由: Na Zhao, et al.
出版: (2020-02-01)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs
由: Lukas von Bredow, et al.
出版: (2022-03-01)

CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis
由: Weifeng He, et al.
出版: (2022-04-01)

Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation
由: Shweta Mishra, et al.
出版: (2024-01-01)

Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding
由: Bernardina Scafuri, et al.
出版: (2020-12-01)

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
由: Beatriz Silva Urias, et al.
出版: (2022-10-01)

Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase
由: Joonhyeok Choi, et al.
出版: (2022-01-01)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
由: Liesbeth Everix, et al.
出版: (2023-02-01)

Overexpression of FRA1 (<i>FOSL1</i>) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression
由: Wuroud Al-khayyat, et al.
出版: (2023-09-01)

HDAC6 Enhances Endoglin Expression through Deacetylation of Transcription Factor SP1, Potentiating BMP9-Induced Angiogenesis
由: Chen Sun, et al.
出版: (2024-03-01)

Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation
由: Nhu Truong, et al.
出版: (2024-01-01)

Design, synthesis, and biological evaluation of substituted benzyl-triazolopyridine derivatives as non-hydroxamate based HDAC8 inhibitors
由: N.V.M. Rao Bandaru, et al.
出版: (2025-04-01)

The replication timing program in the hands of two HDACs
由: Kazumasa Yoshida, et al.
出版: (2014-07-01)

Emerging role of HDAC11 in skeletal muscle biology
由: Jihong Chen, et al.
出版: (2024-05-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
由: Masumeh Sanaei, et al.
出版: (2019-01-01)

Synovial Fluid Derived from Human Knee Osteoarthritis Increases the Viability of Human Adipose-Derived Stem Cells through Upregulation of FOSL1
由: Hironori Kitajima, et al.
出版: (2023-01-01)